Press release
NASH/MASH Treatment Market Set to Quadruple by 2033: Unveiling Future Trends and Billion-Dollar Opportunities
NASH/MASH Treatment Market
📌 Download your Exclusive Sample Report Today: (Corporate Email gets priority access):- https://www.datamintelligence.com/download-sample/nash-or-mash-treatment-market?kb
☛ Nash/Mash Treatment Market Recent Developments 2025:
United States: Recent Industry Developments
✅ In July 2025, SkyCharge Inc. launched an automated drone battery swapping station in Texas. The system enables commercial delivery drones to swap batteries in under 90 seconds, increasing operational efficiency by 40%.
✅ In June 2025, DroneX partnered with a California-based logistics company to integrate battery swapping solutions into its delivery fleet. Full deployment is expected by Q1 2026, supporting same-day deliveries.
✅ In May 2025, AeroPower introduced a modular battery swapping system for agricultural drones. The system extends flight time for crop monitoring and spraying applications, representing a $10 million investment in sustainable drone operations.
Japan: Recent Industry Developments
✅ In July 2025, NEC Aviation unveiled a rapid battery swapping hub for industrial drones in Tokyo. The hub focuses on minimizing downtime for inspection and surveillance drones in urban areas.
✅ In June 2025, Yamaha Motor developed a smart battery swapping solution for delivery drones, incorporating IoT monitoring for real-time battery health tracking. Pilot testing is underway in Osaka.
✅ In May 2025, SoftBank Robotics partnered with regional airports to deploy battery swapping stations for logistics and inspection drones. The initiative aims to enhance drone flight efficiency across Japan's airspace.
☛ Nash/Mash Treatment Market: Drivers
The NASH/MASH treatment market is gaining momentum due to the increasing prevalence of metabolic disorders such as obesity, type 2 diabetes, and dyslipidemia. Nonalcoholic steatohepatitis (NASH) and metabolic dysfunction-associated steatohepatitis (MASH) have emerged as major liver diseases linked to sedentary lifestyles and unhealthy dietary habits. Growing awareness of the long-term consequences of untreated liver inflammation, including cirrhosis and hepatocellular carcinoma, is driving demand for effective therapeutics. Pharmaceutical companies are accelerating R&D to develop novel drugs targeting fibrosis, inflammation, and lipid metabolism. Rising healthcare spending and improved diagnostic capabilities are further supporting the adoption of early treatment options.
Advancements in biomarker research and imaging technologies are enhancing early detection and clinical management of NASH/MASH, contributing to the expansion of the treatment landscape. The introduction of non-invasive diagnostic tools is enabling more patients to access care without liver biopsy procedures, boosting treatment uptake. Strategic collaborations between biotech firms and research institutions are expediting clinical trials for promising drug candidates. Additionally, government initiatives to address the rising burden of chronic liver diseases are fostering a favorable regulatory environment. With increasing patient awareness and pipeline innovation, the NASH/MASH treatment market is poised for significant growth in the coming years.
📌 Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/nash-or-mash-treatment-market?kb
☛ Nash/Mash Treatment Market: Major Players
Novo Nordisk A/S, Boehringer Ingelheim International GmbH., 89bio, Inc., Inventiva., CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD, Sagimet Biosciences., and Akero Therapeutics, Inc.
Research Methodology
We follow a hybrid research approach, combining qualitative insights with rigorous quantitative analysis to deliver reliable and comprehensive market intelligence. Our process begins with extensive secondary research, drawing on trusted industry reports, proprietary databases, and credible market sources. This is then reinforced through targeted primary research, including structured surveys and in-depth interviews with industry leaders, subject matter experts, and key market participants.
☛ Segments Covered in the Nash/Mash Treatment Market:
By Drug: Resmetirom (Rezdiffra) | Lanifibranor | Semaglutide | Survodutide | Pegozafermin | Efruxifermin | Denifanstat | Others
By Stage: Stage 0-1 | Stage 2-3 | Stage 4
By Age Group: Pediatrics | Adults | Geriatrics
By Gender: Male | Female
📌 Get Corporate Access to Live Nash/Mash Treatment Industry Intelligence Database: https://www.datamintelligence.com/buy-now-page?report=nash-or-mash-treatment-market?kb
☛ Regional Analysis for Nash/Mash Treatment Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
📌 Request for 2 Days FREE Trial Access: https://www.datamintelligence.com/reports-subscription
☛ Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring
☛ Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release NASH/MASH Treatment Market Set to Quadruple by 2033: Unveiling Future Trends and Billion-Dollar Opportunities here
News-ID: 4217154 • Views: …
More Releases from DataM Intelligence 4market Research LLP
United States Sweet Corn Seeds Market Growth at 4.2% CAGR: Hybrid Varieties and …
The Global Sweet Corn Seeds Market reached US$ 802.10 million in 2022 and is expected to reach US$ 1114.73 million by 2031, growing with a CAGR of 4.2% during the forecast period 2024 to 2031., according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Syngenta expanded its U.S. hybrid sweet corn seed portfolio with a new disease-resistant yellow variety, partnering with major growers in Florida to boost yields…
United States Oncology Biosimilars Market Expands at 18.6% CAGR, Powered by Key …
The global oncology biosimilars market size reached US$ 6.76 Billion in 2024 from US$ 5.77 Billion in 2023 and is expected to reach US$ 30.83 Billion by 2033, growing at a CAGR of 18.6% during the forecast period 2025 to 2033., according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, Amgen Inc. expanded its U.S. oncology biosimilars portfolio with a new interchangeable designation for its filgrastim variant, partnering…
United States Superfood Boom Drives Mulberry Market (4.8% CAGR): Unlock Growth i …
The Mulberry Market reached USD 38.1 billion in 2022 and is expected to reach USD 55.4 billion by 2031 growing with a CAGR of 4.8% during the forecast period 2024 to 2031., according to DataM Intelligence.
United States: Recent Industry Developments
✅ In October 2025, BioSpectrum expanded its U.S. organic mulberry extract production by 25%, partnering with wellness brands like Nature's Bounty to enhance supplement formulations for antioxidant-rich immune support.
✅ In September…
Water-Based Adhesive Market Insights 2025: Technologies & Applications | Leading …
Leander, Texas, United States - Nov. 19. 2025 " Water-Based Adhesive Market is anticipated to grow at high CAGR during the forecast period 2024-2031. "
The Water-Based Adhesive Market is driven by increasing demand for eco-friendly, low-VOC bonding solutions across packaging, woodworking, automotive, and construction industries. Market growth is supported by rising environmental regulations, advancements in polymer technologies, and the shift toward sustainable and high-performance adhesive formulations.
➠ Download Your Sample…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
